Patents by Inventor Cezary Marcinkiewicz

Cezary Marcinkiewicz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Soy-Derived Bioactive Peptides for Use in Compositions and Methods for Wound Healing, Tissue Engineering, and Regenerative Medicine
    Publication number: 20220211804
    Abstract: Compositions and methods for the promotion of wound healing and tissue regeneration are described. The compositions and methods make use of water-soluble soy protein isolates (WSsoy), Fraction 5, Fraction 9, and/or bioactive peptide components of soy protein isolates. The invention also relates to the unexpected discovery that purified WSsoy forms gel-like matrices when suspended within certain concentration ranges in an aqueous environment. The compositions of the invention comprising WSsoy promote natural healing and have a low risk profile.
    Type: Application
    Filed: August 2, 2021
    Publication date: July 7, 2022
    Inventors: Peter I. Lelkes, Yah-el H. Har-el, Cezary Marcinkiewicz, Philip Lazarovici, Sogol Moaiyed Baharlou, Jonathan A. Gerstenhaber
  • Soy-derived bioactive peptides for use in compositions and methods for wound healing, tissue engineering, and regenerative medicine
    Patent number: 11077169
    Abstract: Compositions and methods for the promotion of wound healing and tissue regeneration are described. The compositions and methods make use of water-soluble soy protein isolates (WSsoy), Fraction 5, Fraction 9, and/or bioactive peptide components of soy protein isolates. The invention also relates to the unexpected discovery that purified WSsoy forms gel-like matrices when suspended within certain concentration ranges in an aqueous environment. The compositions of the invention comprising WSsoy promote natural healing and have a low risk profile.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: August 3, 2021
    Assignee: TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: Peter I. Lelkes, Yah-El H. Har-el, Cezary Marcinkiewicz, Philip Lazarovici, Sogol Moaiyed Baharlou, Jonathan A. Gerstenhaber
  • Soy-Derived Bioactive Peptides for Use in Compositions and Methods for Wound Healing, Tissue Engineering, and Regenerative Medicine
    Publication number: 20180207232
    Abstract: Compositions and methods for the promotion of wound healing and tissue regeneration are described. The compositions and methods make use of water-soluble soy protein isolates (WSsoy), Fraction 5, Fraction 9, and/or bioactive peptide components of soy protein isolates. The invention also relates to the unexpected discovery that purified WSsoy forms gel-like matrices when suspended within certain concentration ranges in an aqueous environment. The compositions of the invention comprising WSsoy promote natural healing and have a low risk profile.
    Type: Application
    Filed: July 21, 2016
    Publication date: July 26, 2018
    Inventors: Peter I. Lelkes, Yah-el H. Har-el, Cezary Marcinkiewicz, Philip Lazarovici, Sogol Moaiyed Baharlou, Jonathan A. Gerstenhaber
  • EC-3, an inhibitor of &agr;4&bgr;1 and &agr;4&bgr;7 integrins
    Patent number: 6818617
    Abstract: This invention relates to the identification, purification, and characterization of a novel heterodimeric disintegrin, EC-3, from Echis carinatus viper venom. EC-3 inhibits &agr;4 integrins in an RGD-independent manner. The invention further relates to methods of using EC-3, or a biologically active fragment or derivative thereof, to inhibit the interaction between cells expressing &agr;4 integrins and cellular ligands.
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: November 16, 2004
    Assignee: Temple University- Of The Commonwealth System of Higher Education
    Inventors: Stefan Niewiarowski, Cezary Marcinkiewicz
  • KTS-disintegrins
    Publication number: 20030186334
    Abstract: A novel class of non-RGD disintegrins is described. These disintegrins have the core sequence KTS, and selectively inhibit the binding of &agr;1&bgr;1 integrin to its adhesive ligands. Two KTS-disintegrins, obtustatin and viperisrastatin, are also described. KTS-disintegrins can be used to treat diseases and modulate biological conditions associated with &agr;1&bgr;1 integrin.
    Type: Application
    Filed: March 11, 2003
    Publication date: October 2, 2003
    Applicant: Temple University - Of the Commonwealth System of Higher Education
    Inventor: Cezary Marcinkiewicz